Smith & Nephew plc (ADR)  

(Public, NYSE:SNN)   Watch this stock  
Find more results for snn
35.31
+0.18 (0.51%)
Real-time:   12:23PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 35.05 - 35.37
52 week 28.87 - 40.36
Open 35.13
Vol / Avg. 223,018.00/497,922.00
Mkt cap 15.89B
P/E 31.83
Div/yield 0.37/1.68
EPS 1.11
Shares 895.63M
Beta 0.92
Inst. own 2%
Apr 30, 2015
Q1 2015 Smith & Nephew PLC Trading Statement Call - 4:00AM EDT - Add to calendar
Apr 30, 2015
Q1 2015 Smith & Nephew PLC Trading Statement Release - 2:00AM EDT - Add to calendar
Apr 9, 2015
Smith & Nephew PLC Annual Shareholders Meeting
Mar 25, 2015
Smith & Nephew PLC Analyst & Investor Breakfast
Mar 24, 2015
Smith & Nephew PLC at Canaccord Genuity Musculoskeletal Conference
Feb 5, 2015
Q4 2014 Smith & Nephew PLC Earnings Call - Webcast
Feb 5, 2015
Q4 2014 Smith & Nephew Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 12.81% 10.85%
Operating margin 18.09% 16.22%
EBITD margin - 30.39%
Return on average assets 8.58% 7.63%
Return on average equity 15.93% 12.39%
Employees 13,468 -
CDP Score - 95 B

Address

15 Adam Street
LONDON, WC2N 6LA
United Kingdom - Map
+44-20-74017646 (Phone)
+44-20-79303353 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Smith & Nephew plc is a global medical devices business operating in the markets for advanced surgical devices consisting orthopaedic reconstruction, trauma and sports medicine and advanced wound management. The Company operates in two segments: Advanced Surgical Devices and Advanced Wound Management. The Company�s Advanced Surgical Devices (ASD) segment offers products and technologies include orthopaedic reconstruction, trauma and extremities, sports medicine joint repair, arthroscopy enabling technologies and other ASD. The Company�s Advanced Wound Management (AWM) segment offers products include Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives. The Company operates across the world and has distribution channels in over 90 countries.

Officers and directors

Olivier Bohuon Chief Executive Officer, Executive Director
Age: 56
Bio & Compensation  - Reuters
Julie Brown Chief Financial Officer, Executive Director
Age: 52
Bio & Compensation  - Reuters
Rodrigo Bianchi President, IRAMEA
Age: 55
Bio & Compensation  - Reuters
Michael G. Frazzette President - Advanced Surgical Devices
Age: 53
Bio & Compensation  - Reuters
R. Gordon Howe President - Global Operations
Age: 52
Bio & Compensation  - Reuters
Diogo Moreira-Rato President - Europe and Canada
Age: 53
Bio & Compensation  - Reuters
Glenn S. Warner President - Advanced Wound Management
Age: 52
Bio & Compensation  - Reuters
John W. Campo Chief Legal Officer
Age: 60
Bio & Compensation  - Reuters
Helen Maye Chief Human Resources Officer
Age: 55
Bio & Compensation  - Reuters
Cyrille Petit Chief Corporate Development Officer
Age: 44
Bio & Compensation  - Reuters